One Stop Shop for All Your Market Research Reports

United States Gene Therapy Sales Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Gene therapy is an experimental treatment that involves introducing genetic material into a person?s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a ?vector.? The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy. Scope of the Report: This report focuses on the Gene Therapy Sales in United States market. This report categorizes the market based on manufacturers, type and application. Market Segment by Manufacturers, this report covers Bluebird Bio Sangamo Spark Therapeutics Dimension Therapeutics Avalanche Bio Celladon Vical Inc. Advantagene Market Segment by Type, covers Ex Vivo In Vivo Market Segment by Applications, can be divided into Cancer Diseases Monogenic Diseases Infectious Diseases Cardiovascular Diseases Other There are 11 Chapters to deeply display the United States Gene Therapy Sales market. Chapter 1, to describe Gene Therapy Sales Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Gene Therapy Sales, with sales, revenue, and price of Gene Therapy Sales, in 2015 and 2016; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016; Chapter 4 and 5, to show the market of Gene Therapy Sales by type and application, with sales market share and growth rate by type, application, from 2011 to 2016; Chapter 6, Gene Therapy Sales market forecast, by type and application, with sales and revenue, from 2016 to 2021; Chapter 7, to analyze the Gene Therapy Sales market development potential except United States, covering China, Southeast Asia, India, Latin America etc. Chapter 8, 9, 10 and 11, to describe sales channel, distributors, traders, dealers, market effect factors, appendix and data source.
Table of Contents United States Gene Therapy Sales Market by Manufacturers, Type and Application, Forecast to 2021 1 Market Overview (Market Segment, Status and Outlook) 1.1 Gene Therapy Sales Introduction 1.2 United States Gene Therapy Sales Market Analysis by Type 1.2.1 Ex Vivo 1.2.2 In Vivo 1.3 United States Gene Therapy Sales Market Analysis by Applications
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 4480
Corporate User US $5680
About this Report
Report ID 21242
Category
  • Medical Devices
Published on 4-Oct
Number of Pages 101
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(47)